Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: dowman who wrote (9611)	7/1/1998 6:43:00 PM
From: Ace	Respond to of 14328

Stock price is sad at this time but biotechs are down. If you look at the company and see the progress they are making...thats what counts to me. Not as many negatives as positives. HIV test issue...It is only one test, and a rapid one. It is moving along. Last I heard they (FDA) are looking at doing two rapid tests at once to confirm, Uni-Gold is one of them. The smart thing about Triby is they saw the difficulty involved in getting FDA approval for HIV and are not relying on this one test to make or break them. Diversification... THE KEY !!!

To: dowman who wrote (9611)	7/1/1998 8:24:00 PM
From: AgAuUSA	Read Replies (1) \| Respond to of 14328

<<Why don't you call the often referenced Dr. Branson and ask him aboutthe facts involving HIV2>> My guess, you havn't talked to anyone at the CDC or Trinity Biotech. Didn't you say: <<I invite you, and all others that should have an interest in this issue, to call the people I have called.>> I have an interest in this issue, and I want the names and conversation date of the people YOU TALKED TO at the CDC and Trinity Biotech. Seems like a simple request to me.